| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
GoutFebuxostatInflammasomeSLC2A9 GLUT9URAT1Rasburicase| 1 | 1972 | Psychosomatic considerations in hyperuricemia and gout. | 
| + | - | nl | Psychosom Med 34(2):165-82 (1972) |
| 2 | 2006 | Diagnosis and management of gout. | 
| + | - | nl | BMJ 332(7553):1315-9 (2006) |
| 3 | 1995 | ABC of rheumatology. Gout, hyperuricaemia, and crystal arthritis. | 
| + | - | nl | BMJ 310(6978):521-4 (1995) |
| 4 | 2009 | Gout--current diagnosis and treatment. | 
| + | - | nl | Dtsch Arztebl Int 106(34-35):549-55 (2009) |
| 5 | 2008 | Febuxostat in the management of hyperuricemia and chronic gout: a review. | 
| + | - | nl | Ther Clin Risk Manag 4(6):1209-20 (2008) |
| 6 | 2006 | EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | 
| + | - | nl | Ann Rheum Dis 65(10):1301-11 (2006) Zhang W |
| 7 | 2006 | EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | 
| + | - | nl | Ann Rheum Dis 65(10):1312-24 (2006) |
| 8 | 1980 | Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology. | 
| + | - | nl | Ann Rheum Dis 39(2):103-17 (1980) |
| 9 | 2009 | Gout. Novel therapies for treatment of gout and hyperuricemia. | 
| + | - | nl | Arthritis Res Ther 11(4):236 (2009) |
| 10 | 2008 | Developments in the scientific and clinical understanding of gout. | 
| + | - | nl | Arthritis Res Ther 10(5):221 (2008) |
| 11 | 2005 | Clinical, humanistic, and economic outcomes of gout. | 
| + | - | nl | Am J Manag Care 11(15 Suppl):S459-64; quiz S465-8 (2005) |
| 12 | 2005 | Understanding treatments for gout. | 
| + | - | nl | Am J Manag Care 11(15 Suppl):S451-8; quiz S465-8 (2005) |
| 13 | 2005 | Diagnosis of gout: clinical, laboratory, and radiologic findings. | 
| + | - | nl | Am J Manag Care 11(15 Suppl):S443-50; quiz S465-8 (2005) |
| 14 | 2005 | Epidemiology of hyperuricemia and gout. | 
| + | - | nl | Am J Manag Care 11(15 Suppl):S435-42; quiz S465-8 (2005) |
| 15 | 2005 | Pathogenesis of gout. | 
| + | - | nl | Ann Intern Med 143(7):499-516 (2005) |
| 16 | 2009 | Imaging of gout: findings and utility. | 
| + | - | nl | Arthritis Res Ther 11(3):232 (2009) |
| 17 | 2007 | Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? | 
| + | - | nl | Arthritis Rheum 57(7):1324-8 (2007) |
| 18 | 2007 | The role of interleukin-1 and the inflammasome in gout: implications for therapy. | 
| + | - | nl | Arthritis Rheum 56(10):3183-8 (2007) |
| 19 | 2004 | Gout: on the brink of novel therapeutic options for an ancient disease. | 
| + | - | nl | Arthritis Rheum 50(8):2400-14 (2004) |
| 20 | 2007 | Assessment of outcome in clinical trials of gout--a review of current measures. | 
| + | - | nl | Rheumatology (Oxford) 46(12):1751-6 (2007) |
| 21 | 2007 | British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. | 
| + | - | nl | Rheumatology (Oxford) 46(8):1372-4 (2007) |
| 22 | 2006 | Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review. | 
| + | - | nl | Rheumatology (Oxford) 45(11):1422-31 (2006) |
| 23 | 2005 | Mechanisms of inflammation in gout. | 
| + | - | nl | Rheumatology (Oxford) 44(9):1090-6 (2005) |
| 24 | 1999 | Management of crystal arthritis. | 
| + | - | nl | Rheumatology (Oxford) 38(10):912-6 (1999) |
| 25 | 1975 | Editorial: An evaluation of the pathogenesis of gouty kidney. | 
| + | - | nl | Kidney Int 8(2):65-71 (1975) |
| 26 | 1989 | Crystal-associated arthropathies. | 
| + | - | nl | AJR Am J Roentgenol 152(4):685-95 (1989) |
| 27 | 2007 | Why is gout so poorly managed? | 
| + | - | nl | Ann Rheum Dis 66(10):1269-70 (2007) |
| 28 | 2010 | Advances in gout: some answers, more questions. | 
| + | - | nl | Arthritis Res Ther 12(5):136 (2010) |
| 29 | 2010 | Mechanisms of inflammation in gout. | 
| + | - | nl | Arthritis Res Ther 12(2):206 (2010) |
| 30 | 2008 | Gout in the spotlight. | 
| + | - | nl | Arthritis Res Ther 10(3):112 (2008) So A |
| 31 | 2010 | How interleukin-1β induces gouty arthritis. | 
| + | - | nl | Arthritis Rheum 62(11):3140-4 (2010) |
| 32 | 2010 | Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer? | 
| + | - | nl | Arthritis Rheum 62(10):2845-9 (2010) Neogi T |
| 33 | 2008 | Management of recurrent gout. | 
| + | - | nl | BMJ 336(7639):329 (2008) |
| 34 | 2008 | The gout diagnosis. | 
| + | - | nl | Cleve Clin J Med 75 Suppl 5(-):S17-21 (2008) |
| 35 | 2008 | The practical management of gout. | 
| + | - | nl | Cleve Clin J Med 75 Suppl 5(-):S22-5 (2008) |
| 36 | 2008 | The pathogenesis of gout. | 
| + | - | nl | Cleve Clin J Med 75 Suppl 5(-):S2-4 (2008) |
| 37 | 2008 | Clinical manifestations of hyperuricemia and gout. | 
| + | - | nl | Cleve Clin J Med 75 Suppl 5(-):S5-8 (2008) |
| 38 | 2006 | Gout in 2006: the perfect storm. | 
| + | - | nl | Bull NYU Hosp Jt Dis 64(1-2):82-6 (2006) |
| 39 | 2010 | Gout and its comorbidities. | 
| + | - | nl | Bull NYU Hosp Jt Dis 68(3):199-203 (2010) |
| 40 | 2007 | Hyperuricemia and gout: new insights into pathogenesis and treatment. | 
| + | - | nl | Bull NYU Hosp Jt Dis 65(3):215-21 (2007) |
| 41 | 2008 | Update on the management of hyperuricemia and gout. | 
| + | - | nl | Bull NYU Hosp Jt Dis 66(3):231-9 (2008) |
| 42 | 2009 | Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. | 
| + | - | nl | Rheumatology (Oxford) 48(3):222-6 (2009) |
| 43 | 2008 | Hyperuricaemia--where nephrology meets rheumatology. | 
| + | - | nl | Rheumatology (Oxford) 47(7):960-4 (2008) |
| 44 | 2005 | Diagnosis and management of gout: a rational approach. | 
| + | - | nl | Postgrad Med J 81(959):572-9 (2005) |
| 45 | 2009 | Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. | 
| + | - | nl | Health Technol Assess 13 Suppl 3(-):37-42 (2009) |
| 46 | 2008 | Gout. | 
| + | - | nl | Clin Evid (Online) 2008(-):- (2008) |
| 47 | 2010 | Gout: a clinical syndrome illustrated and discussed. | 
| + | - | nl | Neth J Med 68(9):352-9 (2010) |
| 48 | 2007 | Learning how and when to employ uricase as bridge therapy in refractory gout. | 
| + | - | nl | J Rheumatol 34(10):1955-8 (2007) |
| 49 | 2005 | Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. | 
| + | - | nl | J Rheumatol 32(5):773-7 (2005) |
| 50 | 2009 | Recent insights into the pathogenesis of hyperuricaemia and gout. | 
| + | - | nl | Hum Mol Genet 18(R2):R177-84 (2009) |